Author

Danny Wilbie

Utrecht UniversityORCID 0000-0003-1004-304XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Enrico MastrobattistaiD· 1 shared Esmeralda BosmaniD· 1 shared Jan J. MolenaariD· 1 shared Johanna WaltheriD· 1 shared Olivier G. de JongiD· 1 shared Selma Eising· 1 shared Vicky Amo-Addae· 1 shared Zhiyong LeiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Enrico MastrobattistaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyPLoS ONEPeer-reviewedSep 26, 2025

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out

Danny Wilbie, Selma Eising, Vicky Amo-Addae…·Enrico Mastrobattista

This study screens cancer drugs to find those that enhance HDR over NHEJ in CRISPR gene editing, identifying Aurora kinase A inhibitors as promising candidates.

3 citations

mouseCRISPR screen

𝕏 PostBluesky